Ulrich Kohnert
17Patents
5h-index
26Co-inventors
66Inventor score
Filing activity: Sep 28, 1990 → Aug 21, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5747030A | Pharmaceutical preparation containing plasminogen activators | Human Necessities | 10 | Expired |
| US5223256A | Thrombolytically active non-glycosylated protein | Human Necessities | 10 | Expired |
| US5409699A | Compositions containing glycosylated molecules having human tissue type plasminogen activator enzymatic activity | Human Necessities | 9 | Expired |
| US5366730A | Stabilized compositions having human tissue type plasminogen activator enzymatic activity | Human Necessities | 9 | Expired |
| US5352452A | Stabilized compositions containing non-glysylated human tissue type plasminogen activator derivative K2P pro | Human Necessities | 5 | Expired |
| US5352453A | Compositions containing non-glycosylated human tissue type plasminogen activator | Human Necessities | 4 | Expired |
| US9150641B2 | Sequence dependent aggregation | Chemistry; Metallurgy | 3 | Active |
| US7763270B2 | Metal implant coated under reduced oxygen concentration with osteoinductive protein | Emerging Cross-Sectional Technologies | 2 | Active |
| US5908625A | Use of the protease domain of human plasminogen activator for the treatment of thromboembolic diseases | Human Necessities | 1 | Expired |
| US6025142A | Hydrophobic u-PAR binding site | Human Necessities | 1 | Expired |
| US5723122A | Use of the protease domain of human plasminogen activator for the treatment of thromboembolic diseases | Human Necessities | 1 | Expired |
| US9187550B2 | Tetranectin-apolipoprotein A-I, lipid particles containing it and its use | Chemistry; Metallurgy | 1 | Active |
| US5973118A | Mutant of the Erythrina caffra type inhibitor and the use of the said mutant for purifying serine proteases | Chemistry; Metallurgy | 1 | Expired |
| US8257728B2 | Metal implant coated under reduced oxygen concentration with osteoinductive protein | Emerging Cross-Sectional Technologies | 0 | Active |
| US8546334B2 | Device having osteoinductive and osteoconductive properties | Human Necessities | 0 | Expired |
| US10047162B2 | Sequence dependent aggregation | Chemistry; Metallurgy | 0 | Active |
| US5958722A | Use of recombinant inhibitor from Erythrina caffra for purifying serine proteases | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.